Corbus Pharmaceuticals

CRBPNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$188.428 M

$10.17 +4.42%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$78.5M

Loss-making

Shares outstanding

19,341,293

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#272Korro BioKRRO$191.1M
#273Lifecore Biomedical, Inc. DeLFCR$189.6M
#274Corbus PharmaceuticalsCRBP$188.4M
#275Oramed PharmaceuticalsORMP$178.9M
#276Journey MedicalDERM$177.0M

Where these numbers come from

Share counts and financials for Corbus Pharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.